Mylan shares surge on EpiPen settlement news
EpiPen said its subsidiary Mylan Inc. has agreed to a $465 million settlement with the Justice Department and other government agencies stemming from the classification of EpiPen for Medicaid rebates. The terms of the settlement “do not provide for any finding of wrongdoing” by Mylan…
The door is now wide open for others to follow their lead.
Meds are the new finance. Pay up or die.